(Q50714887)

English

Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

scientific article published in December 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sara Prutchi-Sagiv

1

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Natalia Golishevsky

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Howard S Oster

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Odelia Katz

4

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Amos Cohen

5

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Elizabeth Naparstek

6

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Drorit Neumann

7

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Moshe Mittelman

8

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

language of work or name

0 references

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

135

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

5

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

660-672

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

Emerging biological roles for erythropoietin in the nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Neuroprotective properties of epoetin alfa.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

A novel role for erythropoietin during fibrin-induced wound-healing response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

CD8+ T-cell clones in old mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Immunoregulatory mechanisms in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Expression of the erythropoietin receptor on a human myeloma cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Immunophenotype and DNA cell content in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06366.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2006.06366.X

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/17107348

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50714887&oldid=1248173676"